Human–Wildlife Conflicts 2(1):93–101, Spring 2008

GnRH immunocontraception of male and
female white-tailed deer fawns
LOWELL A. MILLER, USDA/APHIS/Wildlife Services’ National Wildlife Research Center, 4101 LaPorte Avenue, Fort Collins, CO 80521, USA Lowell.A.Miller@usda.gov
JAMES P. GIONFRIDDO, USDA/APHIS/ Wildlife Services’ National Wildlife Research Center, 4101
LaPorte Avenue, Fort Collins, CO 80521, USA
JACK C. RHYAN, USDA/APHIS/ Wildlife Services’ National Wildlife Research Center, 4101 LaPorte
Avenue, Fort Collins, CO 80521, USA
KATHLEEN A. FAGERSTONE, USDA/APHIS/ Wildlife Services’ National Wildlife Research Center,
4101 LaPorte Avenue, Fort Collins, CO 80521, USA
DONALD C. WAGNER, Almquist Research Center, The Pennsylvania State University, University
Park, PA 16802, USA
GARY J. KILLIAN, Almquist Research Center, The Pennsylvania State University, University Park,
PA 16802, USA

Abstract: Immunocontraceptive vaccines based on gonadotropin-releasing hormone

(GnRH) have been tested in adult white-tailed deer (Odocoileus virginianus), but their effects
on fawns are unknown. The purpose of this study was to determine if early immunization
against GnRH would induce a long-lasting immune response in fawns, and if it would delay
or prevent sexual development. We gave primary and subsequent booster injections of a
KLH-GnRH/Freund’s vaccine to 6 male and 6 female fawns. This vaccine contained the
same active ingredients as GonaCon™ vaccine, but it contained Freund’s adjuvant instead
of AdjuVac™ adjuvant. Two 450-μg injections were given 1 month apart when fawns were 3
and 4 months of age. Although 1 female fawn produced a multiyear contraceptive response
similar to that observed previously in vaccinated adults, the immune response lasted only
1 year in the other 11 fawns. Antibody titers in those 11 fawns declined sharply to near
zero during the second and third years after vaccination. Our results indicate that treating
3- to 4-month-old white-tailed deer with the GnRH vaccine did not induce contraception or
sterilization, and it did not delay or prevent sexual development. No adverse health effects
were apparent in GnRH-treated fawns.
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Deer–vehicle collisions (DVCs) and other
deer–human conflicts are becoming more frequent in rural areas (Storm et al. 2007), suburbia
(Hussain et al. 2007), and urban areas. DVCs
cause damage to vehicles and injuries and
fatalities to humans (Conover 1997, 2001). There
are no panaceas for reducing the frequencies of
DVCs, but reducing deer densities may be 1
option. There is great interest in developing an
eﬀective method to contracept deer as a way to
lower local deer densities and DVCs.
Adult white-tailed deer (Odocoileus virginianus) of both sexes have been temporarily
rendered infertile by vaccination with an immunocontraceptive vaccine consisting of a
gonadotropin-releasing hormone (GnRH)
conjugate combined with Freund’s adjuvant
(Miller et al. 2000). Vaccines used in early
studies consisted of GnRH conjugated to
a mollusk carrier protein (keyhole limpet

hemocyanin, or KLH). The large size and
foreign (non-self) nature of KLH greatly increased the immunogenicity of GnRH, which
(if unconjugated) is a weak antigen. Multiple
(primary and subsequent booster) injections
of vaccine were used to induce strong immune
responses in adult white-tailed deer (Miller et
al. 2000, Miller and Killian 2001). A diﬀerent
mollusk protein (blue protein) has been used in
place of KLH since 2004 as a carrier molecule to
which synthetic GnRH is attached. Both KLH
and blue protein formulations of GonaCon™
are emulsified with a newly developed adjuvant
called AdjuVac™. AdjuVac replaced Freund’s
adjuvant in the vaccine at the urging of the U.S.
Food and Drug Administration due to concerns
over Freund’s safety.
An application was submitted to the U.S.
Environmental Protection Agency during 2007
for registration of GonaCon as a contraceptive
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agent for use in female white-tailed deer. We
anticipate that GonaCon will be registered as
a restricted-use product that will be labeled
for use by state and federal wildlife or natural
resource management personnel or persons
working under their authority. GonaCon users
also will be required to follow state authorization processes and regulations.
GonaCon vaccine has been tested as a singleinjection contraceptive agent in domestic
hogs (Sus scrofa; Miller et al. 2004b), feral hogs
(Killian et al. 2004b, 2006c), bison (Bison bison;
Miller et al. 2004a), California ground squirrels
(Spermophilus beecheyi; Nash et al. 2004), feral
cats (Felis catus; Levy et al. 2004), black-tailed
deer (Odocoileus hemionus; Perry et al. 2006), and
free-ranging horses (Equus caballus; Killian et al.
2004a, 2006b). GonaCon has also been tested
for toxicity in white-tailed deer (Killian et al.
2006a). The results of these and other studies
(Miller et al. 2004c) suggested that GonaCon
vaccine is both safe and potentially useful as a
wildlife contraceptive agent in a wide range of
mammalian species.
The contraceptive eﬀect of vaccination with
GonaCon was greater and longer lasting in
females than in males (Killian et al. 2004b, 2006c).
Male deer treated with GonaCon exhibited abnormal antler development associated with
reduced serum androgens. These findings
prompted our recommendation that GonaCon
vaccine use in deer be limited to treatment of
females (Killian et al. 2005).
Reproductive inhibitors must be tailored
to the physiology of the target animal, as no
contraceptive agent is eﬀective, practical, and
appropriate for use in all species (Fagerstone
et al. 2002) or age classes. Although GonaCon
safely and eﬀectively causes temporary infertility in adult deer, its eﬀects on fawns are
unknown. This paper describes eﬀorts to determine whether injecting 3-month-old whitetailed deer fawns with GonaCon vaccine would
induce a long-lasting immune response or aﬀect
sexual development.

Methods
White-tailed deer fawns used in this study
were born and maintained at the Pennsylvania
State University (PSU) Deer Research Center
in University Park, Pennsylvania, where they
were kept in outdoor paddocks that ranged

in size from 0.12 ha to 1.5 ha (0.3 acres to 3.8
acres). Vegetation in the paddocks consisted
of a mixture of clover and orchard grasses and
eastern deciduous forest. The study was approved by the Institutional Animal Care and
Use Committee of PSU.
Six male and 6 female white-tailed deer fawns
each were given 2 injections of 450-μg KLHGnRH-Freund’s vaccine; a primary injection was
given at 3 months, and a booster injection was
given at 4 months of age. Blood samples were
collected from all fawns in September before the
primary injection, in October before the booster
injection, and during the following November and February. Blood was centrifuged, and
progesterone concentrations and anti-GnRH
antibody titers were measured in the recovered
serum. Similar collections and evaluations of
blood samples occurred during the second
and third years of the 3-year study, although
no additional GnRH vaccinations were given.
During the autumn breeding season each year,
adult bucks of proven fertility were kept in the
enclosure with the study deer to serve as sires.
To determine pregnancy, ultrasonography was
performed each February on every female fawn.
We documented the development and shedding
of antlers by males each year. We assessed the
sexual development of the female fawns by
measuring serum progesterone concentrations
as an indicator of ovarian function. Evaluation of males consisted of measuring serum
testosterone concentrations and observing and
documenting antler development and scrotal
testis length.

Progesterone assay
We used the Coat-A-Coat™ Progesterone Invitro Diagnostic Test Kit (Diagnostic Products,
Los Angeles, Calif.) in these studies, and we
followed the manufacturer’s recommended
procedure.

Antibody response
We used an enzyme-linked immunosorbent
assay (ELISA) to assess immune responses to the
GnRH vaccine. A 96-well plate was prepared by
adding 100 ng of BSA (bovine serum albumin)GnRH antigen to each well and blocking with
SeaBlock™ from Pierce Chemical (Rockford,
Ill.). (Blocking prevented binding of antibody to
plastic in the ELISA plate.) Because GnRH-KLH
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dropped to nondetectable levels by February
1999 (e.g., Figures 1, 2). The immune response
of the sixth female fawn (no. 976) also had
waned by February 1999, but then the animal
appeared to self-boost, as the antibody level
increased dramatically and remained elevated
throughout the final 2 years of the study (Figure
3).
Ultrasonography. As expected, the initial
ultrasound examinations during February
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was used in the vaccine, BSA-GnRH was put on
the ELISA plate, and, thus, only antibodies to
GnRH were detected.
We serially diluted deer blood serum from
1:1,000 to 1: 256,000 in phosphate-buﬀered
saline containing SeaBlock. Antibodies in the
deer serum to GnRH on the plate were directed with the following linkage: deer antiGnRH binds to the GnRH on the plate, rabbit anti-deer immunoglobulin G (IgG) binds
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Blood sampling date
FIGURE 1. (Female no. 968) A very strong initial immune response declined sharply to non-detectable levels
within several months, and the doe produced twin fawns in 2000 and 2001. Peaks in serum progesterone
concentrations during February 2000 and 2001 indicated pregnancy.

to the deer IgG, goat anti-rabbit-peroxidase
binds to the rabbit IgG. We used chromogen
(tetramethylbenzidine) to develop the color
and 2M H2SO4 to stop the reaction. We read
the color intensity of the sample at 450 nm
with a Dynatech MR 5000 ELISA plate reader
(Dynatech Laboratories, Alexandria, Va.).

Females

Results

Antibody response. All female fawns responded to the primary and booster vaccinations
by producing anti-GnRH antibody titers of
1:128,000 by October or November 1998. In 5
of these 6 fawns, however, titers subsequently

1999 all indicated non-pregnancy because the
fawns had been only 4 to 6 months old during
the breeding season in fall 1998 (Figures 1‒3).
During autumn 1999, 1 of the 6 female fawns
died from severe pneumonia, and another
died from chronic rumenitis. Both diseases
are common causes of death in captive whitetailed deer in Pennsylvania (Hattel et al. 2004)
and elsewhere in North America (Haigh et al.
2005). Ultrasonography performed in February
2000 and 2001 indicated pregnancy in 3 of the
4 surviving fawns. All 3 of these fawns had
had low anti-GnRH antibody titers 1 year after
vaccination, and, thus, they probably no longer
exhibited anti-GnRH contraceptive activity (in-
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Blood sampling date
FIGURE 2. (Female no. 921) A strong initial immune response declined to non-detectable levels within
several months. Twin fawns were produced in 2000, and triplets were produced in 2001. Minor elevations in
serum progesterone concentrations during winters probably indicated estrous cycling and pregnancy.
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FIGURE 3. (Female no. 976) A strong initial immune response began to decline and then sharply increased
to a very high level by September 1999 due to an apparent self-boost. The anti-GnRH antibody level remained elevated and provided a contraceptive effect throughout the remainder of the study.
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fertility; Figures 1, 2). In contrast, fawn no. 976
apparently self-boosted between February and
September 1999, and then maintained a high
level of anti-GnRH antibody, was identified as
non-pregnant by ultrasound examination in all
3 years, and remained infertile (Figure 3).
Progesterone. In blood samples collected during the fall breeding seasons in 1998–2000,
we observed only slight elevations in serum
progesterone concentrations, probably associated with the estrous cycle (Figures 1‒3).
Mean monthly progesterone concentrations in
September, October, and November (all 3 years)
ranged from 0.1 to 1.5 ng/ml.
Fawn Production. As noted above, fawn no.
976 was infertile throughout the study. During
the second and third years of the study, the 3
remaining fawns bore twins and triplets, with a
mean of 2.3 fawns per doe per year.
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level by February 1999 (Figure 4). In November
1999, one of the males with an initially high
(1:128,000) titer died (cause unknown). Titers
of the other 4 bucks that had initially produced
high anti-GnRH titers dropped to the 1:4,000 to
1:16,000 range during the first year (Figure 5).
During the third year, titers of 2 of these 4 males declined to nondetectable levels, while the
remaining 2 males maintained titers of 1:2,000
to 1:4,000.
Serum testosterone concentrations. As expected,
serum testosterone concentrations in all male
fawns were undetectable throughout the first
year, regardless of anti-GnRH antibody titers.
Throughout the remainder of the study, all
surviving males except one (fawn no. 957;
Figure 4) maintained abnormally low testosterone concentrations (0.2 to 1.8 ng/ml during the autumn rut). In contrast, during the
second and third years of the study, male fawn
no. 957 exhibited testosterone concentrations
that ranged from 5.2 ng/ml to 13.5 ng/ml.
Antler development. Antler development in
fawn number 957 was normal throughout the
study. In the other surviving males, antler development was reduced during the second year
and was normal during the third year.
Scrotal testis length. Scrotal testis length in

Males
Antibody response. Anti-GnRH antibody responses generally were strong but of short duration (≤1 year). By October or November of the
first year (1998), 5 of the 6 males had produced
antibody titers of at least 1:128,000. Male fawn
957 produced a titer of 1:32,000 during the first
year, but this value declined to a nondetectable
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FIGURE 4. (Male no. 957) A moderately strong initial immune response declined to non-detectable levels
within several months. Sexual development in this male was not delayed; it followed the pattern typical of
unvaccinated males.

Human–Wildlife Conflicts 2(1)

98

Female Fawn 976
Anti-GnRH antibody titer

Progesterone

100

12
10
8
6
4

2/7/01

11/1/00

9/20/00

2/9/00

11/9/99

10/26/99

9/23/99

2/9/99

0
11/10/98

0
10/13/98

2
9/15/98

50

Progesterone (ng/ml)

150

indicated
not pregnant

200

Ultrasound

250

Ultrasound
indicated
not pregnant

Ultrasound
indicated
not pregnant

14

-1

Antibody titer (x 1,000)

300

Blood sampling date
FIGURE 5. (Female no. 976) A very strong initial immune response dissipated within a year. Serum testosterone concentrations and antler growth were reduced through February 2001. By November 2001, the
serum testosterone concentration had returned to the normal range.
male fawn no. 957, which had the weakest
immune response to the vaccine, was 70 mm
and 84 mm, respectively, in the second and
third years. Scrotal testis lengths among the
remaining males ranged from 1.0 to 5.6 mm in
the second year and from 5.1 to 8.3 mm in the
third year.

Discussion
The strong initial immune responses of female and male fawns to vaccination with the
KLH-GnRH/Freund’s formulation of GonaCon
vaccine used in this study were similar to
those observed previously in adult deer injected with that vaccine formulation or with
a more recently-developed GonaCon vaccine
formulation that incorporated blue protein and
AdjuVac adjuvant. Anti-GnRH antibody titers in
the fawns, however, declined relatively rapidly.
During the 3-month period before February
1999, high initial antibody levels dropped sharply to nondetectable levels in 5 of the 6 female
fawns. Titers in male fawns declined more
slowly than in females, but at a much more
rapid rate than was observed previously in
adults (Miller et al. 2000). An exception to the
general pattern exhibited by the fawns in this

study was the anti-GnRH antibody pattern
observed in female fawn number 976 (Figure
3), which was typical of that of adult does vaccinated with GonaCon (Miller et al. 2000).
Anti-GnRH antibody levels ≥1:64,000 generally are associated with infertility in adult
white-tailed deer (Miller et al. 2000). In earlier
studies, adult white-tailed does given primary
and booster (1,000 μg per dose, given 2 months
apart) injections of KLH-GnRH-AdjuVac vaccine typically remained infertile for up to 4
years, with an apparent self-boosting eﬀect
often occurring during the fall of the third year
(L. A. Miller, unpublished data). The failure of
female and male fawns in this study to sustain
an initially strong antibody response may be
related to a lack of “immune maturity” (Tizard
2000).
Elevated serum progesterone concentrations
in 2 female fawns during November 1998 (6.0
ng/ml in fawn no. 905 [not illustrated]; 2.9 ng/ml
in fawn no. 921 [Figure 2]) may have indicated
that these deer were cycling. As these fawns
were about 5 months old at the time of blood
sampling, these elevated concentrations may
have been associated with estrus at puberty.
All other elevated progesterone concentrations
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observed in this study were associated both
with ultrasound examinations that indicated
pregnancy and with subsequent fawning.
Although fawn no. 976 was infertile throughout the 3-year study, the other 3 surviving
female fawns each produced an average of 2.3
fawns per year during the last 2 years of the
study. Mean fawn production among adult
does in the PSU deer herd was 1.7 fawns per
doe per year (Miller et al. 2000), with single
fawns typically resulting from first pregnancies. The relatively high rates of twin and triplet
production in the present study may be due to
a rebound phenomenon related to the decrease
in anti-GnRH antibody levels. Similar rates
of twin and triplet production have not been
observed in GnRH-vaccinated adult does. In
fact, GnRH-treated adult deer often produce
single fawns during the first year after antiGnRH antbody titers have declined, and then
twins are produced during subsequent years
(G. J. Killian, unpublished data).
Development of testes and antlers in cervids
are directly related to testosterone levels (Verme
and Ullrey 1984). Vaccination of adult male
deer with GonaCon vaccine indirectly aﬀects
testicular and antler development by reducing
testosterone concentrations (Killian et al. 2005).
Mean scrotal testis length in adult deer in
the PSU deer herd is 74 mm, in contrast to a
mean length of 40 mm in GnRH-treated adult
bucks (Killian et al. 2005). Although testicular
development in male fawn no. 957 was normal,
it was greatly suppressed in the other male
fawns in which testes remained substantially
smaller than normal during the third year of
the study. The comparatively weak and shortlived immune response by male fawn no. 957
suppressed serum testosterone concentrations
only briefly, and it appeared to have no longterm contraceptive or developmental eﬀects.
On the other hand, the other male fawns
showed stronger and longer-lasting immune
responses to vaccination with GonaCon. In
those males, testosterone suppression persisted
into the second and third years, with a resultant
reduction in the developmental rates of testes
and antlers.
GonaCon’s multiyear contraceptive eﬀect
appears to be due to antigen retention caused
by a water-in-oil emulsion that provides a slow
release of the antigen from the injection depot
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site. The retained antigen (GnRH) is present
long enough that the antibody combines with
GnRH to form GnRH-specific immune complexes (ICs). Retention of these ICs through
their binding to follicular dendritic cells (FDCs)
provides 2 functions: (1) it increases the duration
of the antigen’s stimulatory eﬀects by protecting
the antigen from destruction by macrophages,
and (2) it dramatically increases the strength
of the immune response through self-boosting.
Bound FDCs and ICs settle into the draining
lymph node where they are closely surrounded
by B-cells to form a germinal center. Due to this
proximity, 1 ng of GnRH released from the FDC
in the draining lymph node can provide a selfboost to the immune system similar in strength
to the boosting eﬀect of μg quantities of the same
antigen in the original vaccine injection. The
boosting eﬀect from the draining lymph node
could, therefore, be 1,000 times the strength of
the initial reaction. The release of GnRH from
the ICs in the lymph node is increased as the
serum anti-GnRH antibody drops, whereas it
is suppressed in the presence of high antibody
levels (Burton et al. 1991, 1994).
In the treated fawns in this study, the
mechanism that supports FDCs and ICs with
the formation of the germinal center may not
have been suﬃciently developed to produce
a normal, adult-like, multiyear contraceptive
response, with the exception of female fawn no.
976. Endogenous GnRH from the hypothalami
of these immature fawns may not have been
released in quantities suﬃcient to produce immune complexes with the circulating, induced
antibody. Without the binding of FDCs to ICs,
a long-term immune response cannot develop
(Burton et al. 1991, 1994).
Perhaps if the fawns in this study had been
several months older when vaccinated, sexual
development already would have been underway, and the associated release of endogenous
GnRH from the hypothalamus already would
have occurred. Had that been the case, the injection of GnRH vaccine might have caused
the formation of GnRH and anti-GnRH ICs
and prompted the self-boosting immunity
previously observed in GonaCon-treated, adult
white-tailed deer. Our results indicate that
treating 3-month-old white-tailed deer fawns
with GnRH vaccine, although safe for the fawns,
is not an eﬀective means of inducing temporary
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contraception, permanent sterilization, or the
Killian, G. J., L. A. Miller, N. K. Diehl, J. C. Rhyan,
delay or prevention of sexual development.
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